KLF3 Antibody

Code CSB-PA012393DSR2HU
Size US$166
Order now
Image
  • Immunohistochemistry of paraffin-embedded human breast cancer using CSB-PA012393DSR2HU at dilution of 1:100

  • Immunohistochemistry of paraffin-embedded human kidney tissue using CSB-PA012393DSR2HU at dilution of 1:100

  • Immunohistochemistry of paraffin-embedded human adrenal gland tissue using CSB-PA012393DSR2HU at dilution of 1:100

Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) KLF3 Polyclonal antibody
Uniprot No.
Target Names
KLF3
Alternative Names
Basic krueppel-like factor antibody; Basic Kruppel like factor antibody; BKLF3 antibody; CACCC box binding protein BKLF antibody; CACCC-box-binding protein BKLF antibody; Klf3 antibody; KLF3_HUMAN antibody; Krueppel-like factor 3 antibody; Kruppel like factor 3 (basic) antibody; MGC48279 antibody; TEF-2 antibody; TEF2 antibody; Transcript ch138 antibody; Zinc finger protein 741 antibody; ZNF741 antibody
Raised in
Rabbit
Species Reactivity
Human
Immunogen
Recombinant Human Krueppel-like factor 3 protein (1-240AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated
Clonality
Polyclonal
Isotype
IgG
Purification Method
Antigen Affinity Purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Form
Liquid
Tested Applications
ELISA, IHC
Recommended Dilution
Application Recommended Dilution
IHC 1:20-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Usage
For Research Use Only. Not for use in diagnostic or therapeutic procedures.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Binds to the CACCC box of erythroid cell-expressed genes. May play a role in hematopoiesis.
Gene References into Functions
  1. Low KLF3 expression is associated with colorectal cancer. PMID: 28423541
  2. Among the mechanosensitive genes, the two transcription factors, HoxA5 and Klf3, contain cAMP-response-elements methylation of which could serve as a mechanosensitive master switch in gene expression in atherosclerosis. (Review) PMID: 25979369
  3. Klf-3 expression is downregulated in human metastatic sarcomas, and Klf-3 levels negatively correlate with miR-182 expression. PMID: 26314219
  4. A feedback loop consisting of microRNA 23a/27a and the beta-like globin suppressors KLF3 and SP1 regulates globin gene expression. PMID: 23918807
  5. B cell differentiation is significantly impaired in the bone marrow, spleen, and peritoneal cavity of Klf3 null mice; the defects are cell autonomous. PMID: 22003205
  6. Low KLF3 is associated with acute myeloid leukemia. PMID: 21470678
  7. KLF3 is an important regulator of several biological processes, including adipogenesis, erythropoiesis, and B cell development. (Review) PMID: 21360637
  8. The recruitment of CtBP and sumoylation are required for full repression by BKLF. PMID: 15684403

Show More

Hide All

Subcellular Location
Nucleus.
Protein Families
Krueppel C2H2-type zinc-finger protein family
Database Links

HGNC: 16516

OMIM: 609392

KEGG: hsa:51274

STRING: 9606.ENSP00000261438

UniGene: Hs.298658

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2025 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*